Fla. governor snubs $1M offer to fund drug database

Despite an offer from Purdue Pharma, makers of OxyContin, to help fund Florida’s long-delayed prescription monitoring program with a $1 million donation, the state’s governor Rick Scott rejected the much-needed assistance. According to this article from the Sun Sentinel, the infusion would keep the database up and running for at least three years – more than enough, many believe, to find long-term funding for the program despite the state’s financial troubles. According to the Drug Enforcement Agency, 34 states currently have prescription drug monitoring programs up and running, raising questions about the real motives behind Scott’s refusal to implement the long-overdue and critically needed system.

To read more about Florida’s trouble implementing the program, go here. For background on the state’s battle with prescription drug abuse in the form of a timeline, go here.

About Dana Owens

Dana Owens is San Francisco-based writer, editor and blogger who works on diverse projects from holistic health research to record label promotion. In addition to lending her editorial eye to Oxy Watchdog, Dana also acts as copyeditor for 99 Series, Inc. and executive assistant/project coordinator for Heartline Productions.
This entry was posted in Policy & Regulation and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *